Meet Dr. Jacques Fontaine

Dr. Fontaineis a thoracic surgeon at the H. Lee Moffitt Cancer Center in Tampa, where he recently was appointed director of the Mesothelioma Research and Treatment Center.

Fontaine is considered one of America’s bright young thoracic surgeons. He joined Moffitt in 2011 and brought his innovative approach to an already well-established team of oncologists, pulmonologists and radiologists.

Moffitt is the third-largest free-standing cancer center in the U.S. and treats more mesothelioma patients than anyone else in the state of Florida.

Fontaine attended McGill University Medical School in Montreal, but he also was trained at Brigham and Women’s Hospital in Boston, where he developed an interest in the treatment of mesothelioma while working with renowned surgeon Dr. David Sugarbaker, M.D.

He previously worked at Brown University Medical School in Providence, Rhode Island. He developed a thoracic surgery program at that teaching hospital. Fontaine has developed an expertise in minimally invasive techniques, including robotic surgery.

His interests include esophageal and lung cancers, thymoma and mesothelioma. Fontaine published a study in 2022 highlighting the importance of integrating histologic grade into staging for esophageal cancer patients.

He believes strongly in the importance of getting mesothelioma patients to the specialty centers that can provide them with the latest and greatest care.

“与这种疾病,找到一个specialist is critical,” he says. “You need someone who really understands it and know how to treat it aggressively to get the best possible outcome.”

Role as Medical Reviewer on Asbestos.com

Fontaine’s decades-long experience in the operating room, research work in clinical trials and board certifications in thoracic and general surgery make him an ideal medical reviewer for The Mesothelioma Center at Asbestos.com, the nation’s most trusted mesothelioma resource.

He ensures the topics and content on many of the informational pages on Asbestos.com meet medical and scientific standards when it comes to diagnosis and treatment of the asbestos-related diseases.